Patients with some gastrointestinal tumors were able to be treated with immunotherapy drugs alone and avoid surgery, ...

An immuno-based treatment targeting cancer cells with mismatch repair-deficiency could help those with the disease treat ...

More and better kinds of screening as well as new, more targeted treatments are making breast cancer less deadly.

The investigational oral tyrosine kinase inhibitor (TKI) zongertinib showed promise in patients with previously treated HER2 ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

Adding pembrolizumab (Keytruda), before and after surgery, to standard adjuvant therapy for locally advanced head and neck ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

From 2010 to 2020, breast cancer deaths among women ages 20-49 declined significantly across all breast cancer subtypes and racial/ethnic groups, with marked declines starting after 2016, according to ...

AACR president received a standing ovation in rousing call to action for the cancer research community's response to funding ...

Cancer survivors who reported feeling cancer-related fatigue or depression reduced their recreational activities nearly ...

Patients with advanced solid tumors experienced significantly improved survival outcomes when receiving a tailored therapy ...